Correction: Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma - Miaoyan Wei; Rujiao Liu; Yunyun Xu; Xiaobing Chen; Chao Liu; Xueli Bai; Xiaochen Zhang; Shuiping Gao; Jialin Li; Zhen Sheng; Jianpo Lian; Wenliang Wang; et al. (BMC Medicine)